🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Sreepriya Prasannan

Sreepriya Prasannan

Life Science Journalist & Editor

Sreepriya Prasannan is the Founder and Lead Editor of Priya Life Science. With a deep passion for the Irish pharmaceutical and MedTech sectors, she specializes in sharing actionable career insights, digital regulatory trends, and GMP compliance strategies.

191
Articles
7
Topics
1219
Min Published
Filter: All 191 Industry 75 Regulatory Affairs 42 Pharmaceutical 25 Biotechnology 16 MedTech 16 LinkedIn 12 Clinical Trials 5

All Articles

Page 12 of 16 — 191 articles
Jazz Pharmaceuticals Strikes Strategic $820M Research Deal with AbCellera for Next-Gen T-Cell Engaging Antibodies
Industry
Jazz Pharmaceuticals Strikes Strategic $820M Research Deal with AbCellera for Next-Gen T-Cell Engaging Antibodies
Discover how Jazz Pharmaceuticals and AbCellera are joining forces in a high-stakes, $820M biopharma collaboration to pioneer next-generation T-cell engaging (TCE) multispecific antibodies targeting gastrointestinal cancers and challenging solid tumors.
18 Jun 2026 8 min
The 47% Problem: Is the Irish Graduate Job Market Broken?
Industry
The 47% Problem: Is the Irish Graduate Job Market Broken?
A staggering 47% of Irish employers have slashed entry-level and graduate roles in 2026. What does this massive structural shift mean for the Class of 2025 and 2026, and how can graduates pivot to survive the "entry-level paradox"?
16 Jun 2026 4 min
Leading CDMO Companies in Ireland: Your Complete Guide to Contract Manufacturing in 2026
Pharmaceutical
Leading CDMO Companies in Ireland: Your Complete Guide to Contract Manufacturing in 2026
A comprehensive guide to the top CDMO companies in Ireland - from Hovione and Thermo Fisher in Cork to EirGen Pharma in Waterford and HiTech Health in Galway. Full profiles, capabilities, certifications, and facilities of Ireland's leading contract development and manufacturing organizations.
16 Jun 2026 18 min
Breckenridge Pharmaceutical Issues Major Recall for Duloxetine Capsules
Regulatory Affairs
Breckenridge Pharmaceutical Issues Major Recall for Duloxetine Capsules
Breckenridge Pharmaceutical has initiated a voluntary recall of hundreds of thousands of bottles of Duloxetine Delayed-Release Capsules due to the presence of nitrosamine impurities exceeding FDA limits.
16 Jun 2026 4 min
Enterprise Ireland Reports Record €38.86bn in Exports: What It Means for Indigenous Life Sciences
Pharmaceutical
Enterprise Ireland Reports Record €38.86bn in Exports: What It Means for Indigenous Life Sciences
Enterprise Ireland has announced record total exports of €38.86 billion. With the Advanced Manufacturing and Life Sciences sector surging by 14% to €13.16 billion, we analyse what this means for Ireland's homegrown pharma ecosystem.
16 Jun 2026 5 min
Council Agrees Mandate on Measures to Advance Biotech Innovation in the EU
Biotechnology
Council Agrees Mandate on Measures to Advance Biotech Innovation in the EU
The Council has agreed its position on targeted amendments to health legislation that seek to boost innovation in the EU's biotechnology sector, updating rules on genetically modified micro-organisms and organ processing.
16 Jun 2026 4 min
Consumer Watchdog Launches Major Probe into Retail Pharmacy Sector Pricing
Regulatory Affairs
Consumer Watchdog Launches Major Probe into Retail Pharmacy Sector Pricing
The Competition and Consumer Protection Commission (CCPC) has launched a comprehensive market study into Ireland's retail pharmacy sector, targeting opaque pricing practices and a lack of competition.
16 Jun 2026 5 min
Ireland in the Crosshairs: How New U.S. Tax Rules and Trade Policies Threaten the Irish Pharma Boom
Pharmaceutical
Ireland in the Crosshairs: How New U.S. Tax Rules and Trade Policies Threaten the Irish Pharma Boom
New U.S. disclosure regulations and aggressive "America First" trade policies from the Trump administration have exposed the massive tax payments of U.S. pharmaceutical giants in Ireland, placing the country's fiscal stability under intense scrutiny.
16 Jun 2026 4 min
The EU Pharma Package and Critical Medicines Act: What Global Companies Need to Know in 2026
Pharmaceutical
The EU Pharma Package and Critical Medicines Act: What Global Companies Need to Know in 2026
The European Union's new General Pharmaceutical Legislation and the Critical Medicines Act have been finalized, representing the most significant overhaul of European medicines law in over two decades. Here is what global companies must know to adapt.
16 Jun 2026 6 min
The European Biotech Act 2026: A Catalyst for Competitiveness and Innovation in Health Biotechnology
Biotechnology
The European Biotech Act 2026: A Catalyst for Competitiveness and Innovation in Health Biotechnology
The European Commission has proposed the European Biotech Act to turbocharge the EU's health biotechnology sector, streamline regulations, and regain global competitiveness against the US and China.
16 Jun 2026 7 min
Avectas: Engineering the Future of Cell Therapy Manufacturing
Pharmaceutical
Avectas: Engineering the Future of Cell Therapy Manufacturing
Recognizing the critical industry bottleneck in scalable cell therapy production, Avectas has announced a landmark collaboration with CCRM and OmniaBio to evaluate its innovative manufacturing platform.
16 Jun 2026 4 min
Navigating Challenges in Oncology: Jazz Pharmaceuticals and PharmaMar Stay Committed Despite Phase 3 Setback
Clinical Trials
Navigating Challenges in Oncology: Jazz Pharmaceuticals and PharmaMar Stay Committed Despite Phase 3 Setback
In the rigorous and highly demanding landscape of oncology research, scientific progress is often non-linear. Recently, Jazz Pharmaceuticals and its partner PharmaMar announced that their Phase 3 trial evaluating Zepzelca did not meet its primary endpoint.
16 Jun 2026 5 min